Sec. 719.
Before initiating a course of psychotropic drug treatment for a recipient, the prescriber or a licensed health professional acting under the delegated authority of the prescriber shall do both of the following:
(a) Explain the specific risks and the most common adverse effects that have been associated with that drug.
(b) Provide the individual with a written summary of the most common adverse effects associated with that drug.
History: Add. 1995, Act 290, Eff. Mar. 28, 1996 ;-- Am. 1996, Act 588, Imd. Eff. Jan. 21, 1997
Last modified: October 10, 2016